ChitogenX Inc. (CHNXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -42 Thousand CAD | 28.81% |
| 2023 | -59 Thousand CAD | 14.49% |
| 2022 | -69 Thousand CAD | 22.47% |
| 2021 | -89 Thousand CAD | 25.21% |
| 2020 | -119 Thousand CAD | -33.24% |
| 2019 | -89.31 Thousand CAD | -268.64% |
| 2018 | -24.22 Thousand CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | -11 Thousand CAD | 0.0% |
| 2024 Q1 | -11 Thousand CAD | 35.29% |
| 2024 Q4 | -9000.00 CAD | 18.18% |
| 2024 FY | -42 Thousand CAD | 28.81% |
| 2024 Q2 | -11 Thousand CAD | 0.0% |
| 2023 Q4 | -17 Thousand CAD | -21.43% |
| 2023 Q1 | -15 Thousand CAD | 16.67% |
| 2023 Q2 | -15 Thousand CAD | 0.0% |
| 2023 FY | -59 Thousand CAD | 14.49% |
| 2023 Q3 | -14 Thousand CAD | 6.67% |
| 2022 Q3 | -18 Thousand CAD | 0.0% |
| 2022 FY | -69 Thousand CAD | 22.47% |
| 2022 Q4 | -18 Thousand CAD | 0.0% |
| 2022 Q2 | -18 Thousand CAD | -20.0% |
| 2022 Q1 | -15 Thousand CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 FY | -89 Thousand CAD | 25.21% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 FY | -119 Thousand CAD | -33.24% |
| 2020 Q1 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 FY | -89.31 Thousand CAD | -268.64% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | -24.22 Thousand CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.28% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 1453.965% |
| SQZ Biotechnologies Company | 9.79 Million USD | 100.429% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 100.359% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.035% |
| Mesoblast Limited | -35.16 Million USD | 99.881% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -22.987% |
| Genus plc | 178.7 Million USD | 100.024% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 110.24% |
| Marizyme, Inc. | 457.7 Thousand USD | 109.176% |
| ContraFect Corporation | -154 Thousand USD | 72.727% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -281.818% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 16.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 154.715% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 163.9% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 89.161% |
| MultiCell Technologies, Inc. | 49.32 USD | 85258.151% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.104% |
| EV Biologics, Inc. | 48.9 Thousand USD | 185.89% |
| Q BioMed Inc. | -8988.00 USD | -367.29% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.149% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -172.303% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.019% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 160.0% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 66.197% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 167.496% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -748.142% |
| Arch Therapeutics, Inc. | -2439.00 USD | -1622.017% |
| IMV Inc. | -962.29 Thousand USD | 95.635% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 129.893% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 56.93% |
| GB Sciences, Inc. | -624.00 USD | -6630.769% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 51.179% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.001% |
| Halberd Corporation | -208.00 USD | -20092.308% |
| Enzolytics Inc. | 30.7 Thousand USD | 236.772% |
| Resverlogix Corp. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 103.095% |
| SYBLEU INC | 11.69 Thousand USD | 459.097% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 108.706% |
| argenx SE | 1.1 Billion USD | 100.004% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.837% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 106.803% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.01% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -374.255% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.095% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 96.321% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 104.251% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 100.437% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 49.91% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.272% |
| ONE Bio Corp. | 20.12 Million USD | 100.209% |
| Reve Technologies, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Agentix Corp. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -254.88% |
| Cell Source, Inc. | - USD | Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 12.97% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 123.788% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 123.788% |
| NovAccess Global Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 91.837% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 93.335% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -44.828% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Qrons Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 109.332% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 86.855% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 100.911% |
| Bioxytran, Inc. | -8285.00 USD | -406.94% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 88.74% |
| Neutra Corp. | 14.33 Thousand USD | 392.989% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 48.78% |
| PureTech Health plc | -1.6 Million USD | 97.38% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 95.805% |
| IXICO plc | 3.27 Million USD | 101.284% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 93.948% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 97.655% |
| CSL Limited | 7.7 Billion USD | 100.001% |
| Cellectis S.A. | 18 Thousand USD | 333.333% |